The global bioreactors market is anticipated to grow at a considerable CAGR of 10.3% during the forecast period (2021-2027). The COVID-19 vaccine is the primary requirement of all nations across the globe. Bioreactors in large quantities are required for the development, production, and storage of these vaccines. Single-used bioreactors are rapidly capturing the market share. For instance, due to the second wave of COVID-19 in India, the demand for single-use bioreactor is grown for the rapid production of vaccines. Earlier static stainless-steel bioreactors were used to grow cells and materials for vaccine development. This setup needs lots of time and money which cannot be afforded in the current COVID-19 situation, that's why bioreactor bags are used as an alternative in which cells are grown with a mixture of ingredients. India is importing these single used bioreactor bags from the US whose supply chain is recently unblocked by the American government.
Browse the full report description of "Global Bioreactor Market Size, Share & Trends Analysis Report by Material (Stainless Steel, and Single-use), By Production (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production) By End-User (Biopharmaceutical Companies and Contract Research Organizations (CRO)) Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/bioreactor-market
The major market players of the bioreactor market are currently focused on the development of bioreactors for the COVID-19 vaccines and other medical drugs. Applikon Biotechnology B.V., acquired by Getinge AB had developed Applikon’s 500 mL miniBio (autoclavable bioreactor) and 500 mL AppliFlex ST (single-use bioreactor) for the research and developments of COVID-19 vaccines which provides optimal ph and temperature for baculovirus-insect cell growth that can replicate spike protein of COVID-19 virus. In March 2021, Getinge had launched a new range of Applikon multi-use bioreactors for academic, government, and biopharmaceutical laboratories.
Similarly, bbi-biotech GmbH in January 2021 had launched GL45 bottle bioreactors in which sterile samples can be extracted, gassed, feed, and even pH-regulated. In March 2020, LAMBDA CZ, s.r.o. had launched LAMBDA MINIFOR 7L for large-scale production of biosurfactant-rhamnolipid. In January 2021, PBS Biotech, Inc. had launched vertical wheel single-use bioreactors that provide homogeneous, low-shear, and scalable mixing. This shows that the pharmaceutical industries are the main driver of the bioreactors market currently which can also further support the market growth in the forecast period.
Market Coverage
o By Material
o By Production
o By End-User
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Bioreactors Market Report Segment
By Material
By Production
By End-User
Global Bioreactors Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/bioreactor-market